Lenox Hill Heart and Vascular Institute, North Shore/LIJ Health System, 130 East 77th Street, 4th Floor Black Hall, New York, NY, 10021-10075, USA.
Curr Atheroscler Rep. 2015 Mar;17(3):488. doi: 10.1007/s11883-015-0488-7.
Transcatheter aortic valve replacement (TAVR) is an alternative and now recommended therapy for patients who meet indications for surgical valve replacement and are high or prohibitive surgical risk. Available TAVR technologies are rapidly emerging to treat this complex patient population. This review discusses the specific valve designs of the transcatheter heart valves currently used, newer generation modifications to overcome limitations of earlier valve designs, and novel imaging modalities, such as computed tomographic angiography-fluoroscopy and echocardiography-fluoroscopy fusion imaging, available for pre-procedural planning and intra-procedural guidance.
经导管主动脉瓣置换术(TAVR)是一种替代疗法,现已被推荐用于符合外科瓣膜置换指征且手术风险高或极高的患者。目前可用于治疗该复杂患者人群的 TAVR 技术正在迅速涌现。本文讨论了目前使用的经导管心脏瓣膜的特定瓣膜设计、为克服早期瓣膜设计局限性而进行的新一代改良,以及用于术前规划和术中引导的新型影像学方法,如计算机断层血管造影-透视和超声心动图-透视融合成像。